{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-096272","form_type":"8-K/A","ticker":"PHGE","cik":"0001739174","company_name":"BiomX Inc.","filed_at":"2026-09-01T21:00:14+00:00","discovered_at":"2026-09-01T21:02:00.403754+00:00","generated_at":"2026-09-01T21:02:14.392819+00:00","sec_items":["8.01","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BiomX announces 1-for-10 reverse stock split effective Sept 9, 2026","bullets":["Reverse split approved by stockholders Aug 25; board fixed ratio at 1-for-10 on Aug 28.","Outstanding shares to drop from ~27.3M to ~2.7M; authorized shares cut from 750M to 150M.","No fractional shares issued; record holders get one whole share for any fractional interest.","Trading on NYSE American split-adjusted from Sept 9; new CUSIP 09090D 608.","Proportionate adjustments to warrants, convertible instruments, and equity awards."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-096272","json":"https://secwatch.observer/filing/0001213900-26-096272.json","markdown":"https://secwatch.observer/filing/0001213900-26-096272.md","text":"https://secwatch.observer/filing/0001213900-26-096272.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026096272/0001213900-26-096272-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026096272/ea0304198-8ka1_biomx.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-01T21:02:14.392819+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}